In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate
- 1 December 2000
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (12), 690-691
- https://doi.org/10.1046/j.1469-0691.2000.00169.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.Journal of Antimicrobial Chemotherapy, 1998
- Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinationsAntimicrobial Agents and Chemotherapy, 1997
- Polycations as outer membrane-disorganizing agentsAntimicrobial Agents and Chemotherapy, 1983
- Rifampin: Spectrum of Antibacterial ActivityClinical Infectious Diseases, 1983